MicroRNA 3976 (miR-3976)

MicroRNA 3976 (miR-3976) is a small, non-coding RNA molecule found in Homo sapiens that acts post-transcriptionally to regulate gene expression. It typically operates by binding to complementary sequences in the 3′ untranslated region (UTR) of target mRNAs, suppressing their translation or promoting their degradation[3][5]. Like other microRNAs, miR-3976 is an important regulatory molecule that can influence diverse cellular processes such as proliferation and apoptosis. Recent research suggests that circulating exosomal miR-3976 levels are elevated in patients with early diabetic retinopathy and may modulate retinal ganglion cell (RGC-5) survival and proliferation, potentially via indirect effects on NFκB pathway signaling[2]. miR-3976 has attracted interest as a candidate biomarker for diabetic retinopathy and may eventually hold therapeutic relevance, though no drugs presently target it directly and further research is required to fully elucidate its molecular and disease roles.

Other names

miR-3976hsa-miR-3976MIR3976

Not applicable (no specific drugs identified as targeting miR-3976) Mechanistically, if targeted, approaches might use antisense oligonucleotides, miRNA mimics, or exosome modulation to influence its activity